Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2004
08/19/2004WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
08/19/2004WO2003088141A3 Device for event detection and method for measuring the activity of neuronal networks
08/19/2004WO2003087821A3 Method for cleaving and deglycosylating antibodies to promote ligand binding
08/19/2004WO2003083067A8 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
08/19/2004WO2003083047A3 MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
08/19/2004WO2003081206A3 Stratification of patient populations having or suspected of having rheumatoid arthritis
08/19/2004WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
08/19/2004WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/19/2004WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
08/19/2004WO2003044531A8 Functionalised support card and use thereof for the rapid diagnosis of an infarct based on an immunotest
08/19/2004WO2003040694A3 Enzymatic cycling assays for homocysteine and cystathionine
08/19/2004WO2003039443A3 Novel genetic markers for leukemias
08/19/2004WO2003016861A3 Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry
08/19/2004WO2003001876A8 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/19/2004US20040162690 Method and system for analyzing test devices
08/19/2004US20040162678 Method of screening for disorders of glucose metabolism
08/19/2004US20040162505 Biopsy needle instrument
08/19/2004US20040162491 Method and device to localize light-emitting regions
08/19/2004US20040162474 Percutaneous biological fluid sampling and analyte measurement devices and methods
08/19/2004US20040162473 Minimally invasive methods of monitoring analyte concentration
08/19/2004US20040162467 Non-invasive transudate extraction
08/19/2004US20040162423 highly hydrophilic content polymethine-based fluorescent markers with high extinction coefficients and a high degree of photostability and storage stability, for use in optical-fluorescent, determination and detection procedures
08/19/2004US20040162353 Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate
08/19/2004US20040162338 Flavanols and procyanidins promote homeostasis
08/19/2004US20040162309 Methods and compositions related to IRM compounds and toll-like receptor 8
08/19/2004US20040162294 Therapeutic use of selective PDE10 inhibitors
08/19/2004US20040162293 Administering to mammal an amount of a selective PDE10 inhibitor effective in treating anxiety or psychotic disorder
08/19/2004US20040162238 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton
08/19/2004US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample
08/19/2004US20040161863 Enhanced immunoassay comprising deoxypyridinoline,digoxin or theophylline in which the degree of agglutination of reactants is used to determine/measure bone density; diagnosing osteoporosis
08/19/2004US20040161862 Detecting and visualizing latent hybridization pattern of nucleic acids on solid support using labeled proteins and precipitation of colloidal particles; nucleic acid hybridization analysis
08/19/2004US20040161861 for enzyme linked immunosorbent assay (ELISA) platform for detecting carbohydrates; solid phase synthesis
08/19/2004US20040161860 Assay with co-immobilized ligands
08/19/2004US20040161859 Lateral flow immunoassay controls
08/19/2004US20040161857 Test strip for chromatography and process for producing the same
08/19/2004US20040161854 Device and method for the determination of lithium ion concentration in a biological fluid
08/19/2004US20040161852 Method of assaying an Fe-Sugar complex
08/19/2004US20040161851 Medical diagnostic apparatus comprising computer program which compare, analyze and monitor past and present analyte patterns and concentrations in bodily fluids; disease diagnosis using bioinformatics
08/19/2004US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV
08/19/2004US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening
08/19/2004US20040161825 Sperm specific proteins
08/19/2004US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering
08/19/2004US20040161821 Density Enhanced Phosphatase-1 (DEP-1); for drug screening agents for altering signal transduction in cells; genetic engineering
08/19/2004US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
08/19/2004US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering
08/19/2004US20040161812 providing a panel of different quantitative blood tests each capable of providing one of an abnormal result for determining whether a patient whose initial clinical evaluation indicates chronic fatigue syndrome, fibromyalgia
08/19/2004US20040161811 Reagent kit for detecting cholesterol in a high-density lipoprotein
08/19/2004US20040161810 for detection/quantitative analysis; serpins (serine proteinase inhibitors); enzyme-linked immunosorbent assay (ELISA); genetic engineering
08/19/2004US20040161808 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria
08/19/2004US20040161807 using labeled substrate molecules that can be acted upon only by specific oncogenic enzymes; for drug screening
08/19/2004US20040161805 Cardiovascular safety assay
08/19/2004US20040161804 Biological measurement system
08/19/2004US20040161803 Methods and reagents for identifying weight loss promoters and therpeutic uses therefor
08/19/2004US20040161802 Methods for producing and improving therapeutic potency of binding polypeptides
08/19/2004US20040161801 Hybridization detection method and biochips
08/19/2004US20040161800 Rubbed substrate surfaces; activation; uniform anchoring of liquid crystals
08/19/2004US20040161799 KOR3like-proteins and methods of modulating KOR3L-mediated activity
08/19/2004US20040161798 Methods and compositions comprising capture agents
08/19/2004US20040161797 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes
08/19/2004US20040161796 Methods, systems, and software for identifying functional biomolecules
08/19/2004US20040161795 Systems and methods for analysis of protein post-translational modification
08/19/2004US20040161794 Identifying modulators of hypothalamic inhibitory factor for use in treatment, prevention and monitoring hypertension
08/19/2004US20040161793 Identifying chemical modulators which prevent bacterial propagation during infection via inhibition of cell cycle protein (FTSZ) assembly; bactericides
08/19/2004US20040161790 Thermodynamic prediction model for biochip DNA hybridization information to be inputted into a neural network system
08/19/2004US20040161788 Sample processing
08/19/2004US20040161787 Protein fragment complementation assays for high-throughput and high-content screening
08/19/2004US20040161786 Gene panel participative in hepatic stellate cell activation
08/19/2004US20040161784 Assays for the detection of microtubule depolymerization inhibitors
08/19/2004US20040161783 Using 16s ribosomal RNA subregions for use as differentiative tools in taxonomic classification of mycobacterium
08/19/2004US20040161780 Using luminescent dyes and colorimetric analysis to detect protein concentration differences in body fluid samples
08/19/2004US20040161776 Mixture comprising multimeric prostate specific membrane antigen (PSMA) for use as tools in diagnosis and treatment of cell proliferative disorders
08/19/2004US20040161771 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4
08/19/2004US20040161768 Comprises nucleotide sequences comprising polymorphic variation in multidrug resistant genes for use in diagnosis and treatment of cancer and cardiovascular disorders
08/19/2004US20040161766 Testing gases and liquids for presence of microbiological toxins using separation elements inside flow through containers; monitoring blood for toxic compounds; pollution control
08/19/2004US20040161762 Novel human poly(a)polymerase gamma (pap gamma)
08/19/2004US20040161760 Using concentration of expression products from cell proliferation marker to diagnosis and prognose leukemic disorders; gene expression analysis and cancer disorders
08/19/2004US20040161758 Identifying/screening ruminant foods and products for presence of viral agents associated with spongiform encephalopathy; immunoassays
08/19/2004US20040161751 A radioactive 32P or 33P phosphine oxide ligand that is useful for radioreceptor binding studies and for diagnostic studies of cancerous tissues; the receptor confers selectively and specificity in delivering lethal radiation to diseased cells
08/19/2004US20040161748 Gridded microarray created by transcription and translation of DNA, or by translation of mRNA, by a cell free system for generating heterologous proteins, domains or peptides; bioreactors
08/19/2004US20040161746 Method of testing allergic disease
08/19/2004US20040161744 Reaction apparatus and method of analyzing biologically active substances using the same
08/19/2004US20040161743 Applications with and methods for producing selected interstrand cross-links in nucleic acids
08/19/2004US20040161741 Microarray comprising immobilized nucleotide sequences and/or derivatives for quantifying RNA expression products
08/19/2004US20040161472 Methods of judging mouth odor
08/19/2004US20040161425 Chemokine receptor antagonists as therapeutic agents
08/19/2004US20040161424 Metabolic enzyme resistance; oral delivery; transporter polypeptides, encoding nucleic acids
08/19/2004US20040161370 Reducing drift; dual differential temperature measurements
08/19/2004US20040161368 Assay system
08/19/2004US20040161367 Filter tube eliminates chlorine vapor by chemical reaction while passing analyte through to detection tube for quantitative colorimetric analysis
08/19/2004US20040161366 Accurate calorimetric determination using multilevel test pads including anthocyanin adsorbent layer; malic acid, lactic acid, residual yeast fermentable sugar, pH
08/19/2004US20040161365 Test strips having a plurality of reaction zones and methods for using and manufacturing the same
08/19/2004US20040161223 Optical waveguide type microplate
08/19/2004US20040160876 Method for determining a tilt angle of an optical pickup head
08/19/2004US20040159547 Gas concentration detector
08/19/2004US20040159146 Method and device for monitoring moisture related operating condition of an immersed solid dielectric material
08/19/2004US20040159145 Method and apparatus for measuring a variable in a lubricant/coolant system
08/19/2004DE19938369B4 Verfahren und Vorrichtung zur Erfassung von Molekülwechselwirkungen über molekulare Motoren Method and apparatus for detecting molecular interactions at the molecular motors
08/19/2004DE10306073A1 Testing of the compressibility of concrete during or immediately after its production, whereby a sample is compressed by vibration and characteristic values measured in order to predict its future compressibility and workability
08/19/2004DE10305579A1 Method for predicting quality characteristic of polymer uses database containing molecular mass distribution and quality characteristic for different polymerization conditions
08/19/2004DE10305222A1 Determining the calcification potential of liquids, useful for causal analysis and treatment selection in cases of calcification disorders, comprises measuring free alpha2-Heremans-Schmid glycoprotein/fetuin